Forget Vertex Pharmaceuticals -- CRISPR Therapeutics is a better buy right now.
Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually ...
Study in Molecular Therapy Oncology shows gene editing restores drug sensitivity by targeting NRF2, with potential across multiple tumor types In a major step forward for cancer care, researchers at ...
Scientists in China report removing HIV from human DNA using gene-editing technology. Experts say the findings are promising but still far from a confirmed cure.
This article examines how CRISPR moved beyond the lab in 2025, proving it can safely and effectively edit genes in patients and crops alike. It highlights a turning point where precision, automation, ...
DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...
At the recent Innovation @ Penn program in San Francisco, leaders debated how gene editing, adaptable platforms and new regulatory processes could move personalized care beyond single-patient wins.
Genomics and genome editing tools took center stage this year, from the Breakthrough Prize in Life Sciences honoring the development of base editing and prime editing to the controversy surrounding ...
CRISPR gene editing has transitioned from a laboratory curiosity to a cornerstone of modern biotechnology, revolutionizing our approach to genetic diseases, including Charcot-Marie-Tooth (CMT) disease ...
In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results